Serotonin 5-HT1A Receptors and Antipsychotics - An Update in Light of New Concepts and Drugs.

Abstract:

:Schizophrenia is characterised by positive, negative, cognitive, depressive and anxiety symptoms. Over the last decades a number of novel treatment strategies with better clinical efficacy and scope, but with lower side-effect profiles have been developed. These have significantly improved the management and prognosis of the disease. Of these approaches, modulation of the serotonergic receptor system is a common, recurring, theme; particularly the use of 5-HT1A receptor agonism as part of or adjunct to existing therapies. Here we review data exploring the utility of 5-HT1A receptor agonists for extending the actions of antipsychotic agents, while limiting their side-effect profile. Notably, interest has grown concerning 5-HT1A receptor activation in schizophrenia because of the development of novel antipsychotics, such as lurasidone and cariprazine, the characterisation of 5-HT1A receptor polymorphisms in schizophrenia patients and the possible beneficial influence of 5-HT1A agonists on neurogenesis.

journal_name

Curr Pharm Des

authors

McCreary AC,Newman-Tancredi A

doi

10.2174/1381612821666150605105215

subject

Has Abstract

pub_date

2015-01-01 00:00:00

pages

3725-31

issue

26

eissn

1381-6128

issn

1873-4286

pii

CPD-EPUB-67895

journal_volume

21

pub_type

杂志文章,评审
  • NAP (davunetide) provides functional and structural neuroprotection.

    abstract::NAP (davunetide) is an eight amino acid peptide (NAPVSIPQ) that has been shown to provide potent neuroprotection, in vitro and in vivo. In human clinical trials, NAP has been shown to increase memory scores in patients suffering from amnestic mild cognitive impairment, a precursor to Alzheimer's disease and to enhance...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211795589373

    authors: Gozes I

    更新日期:2011-01-01 00:00:00

  • Biohybrid Membrane Systems and Bioreactors as Tools for In Vitro Drug Testing.

    abstract::In drug development, in vitro human model systems are absolutely essential prior to the clinical trials, considering the increasing number of chemical compounds in need of testing, and, keeping in mind that animals cannot predict all the adverse human health effects and reactions, due to the species-specific differenc...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666161025155616

    authors: Salerno S,Bartolo L

    更新日期:2017-01-01 00:00:00

  • The Role of TGF-β Signaling Regulatory MicroRNAs in the Pathogenesis of Colorectal Cancer.

    abstract::Colorectal cancer (CRC) is one of the most common cancers globally and is associated with a high mortality rate. The transforming growth factor beta (TGF-β) signaling pathway plays an important role in normal intestinal tissue function, but has also been implicated in the development of CRC. MicroRNAs (miRNAs) have al...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666190110150705

    authors: Moradi-Marjaneh R,Khazaei M,Ferns GA,Aghaee-Bakhtiari SH

    更新日期:2018-01-01 00:00:00

  • Male and female rats differ in brain cannabinoid CB1 receptor density and function and in behavioural traits predisposing to drug addiction: effect of ovarian hormones.

    abstract::Sex-dependent differences are frequently observed in the biological and behavioural effects of substances of abuse, including cannabis. We recently demonstrated a modulating effect of sex and oestrous cycle on cannabinoid-taking and seeking behaviours. Here, we investigated the influence of sex and oestrogen in the re...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/13816128113199990430

    authors: Castelli MP,Fadda P,Casu A,Spano MS,Casti A,Fratta W,Fattore L

    更新日期:2014-01-01 00:00:00

  • AMPA receptor antagonists with additional mechanisms of action: new opportunities for neuroprotective drugs?

    abstract::Ischaemic stroke of the brain accounts for about one third of all deaths in industrialized countries. Many of the patients who survive are severily impaired. Thus, there is an enormous need for pharmacotherapy for the treatment of ischaemic stroke. Why is such a treatment not available yet? Are the pathophysiological ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612024607135

    authors: Weiser T

    更新日期:2002-01-01 00:00:00

  • PET imaging in clinical drug abuse research.

    abstract::Over the last two decades, SPECT (single photon emission computed tomography) and especially PET (positron emission tomography) have proven increasingly effective imaging modalities in the study of human psychopharmacology. Abusing populations can be studied at multiple times after abstinence begins, to give informati...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161205774424717

    authors: Gatley SJ,Volkow ND,Wang GJ,Fowler JS,Logan J,Ding YS,Gerasimov M

    更新日期:2005-01-01 00:00:00

  • Viral diagnostics and antiviral therapy in hematopoietic stem cell transplantation.

    abstract::Viral infections are important causes of morbidity and mortality in hematopoietic stem cell transplant (HSCT) recipients. Some viruses, such as the respiratory and gastrointestinal viruses, are acquired from the healthcare or community in the midst of or after HSCT. Other viruses, such as the herpes-virus family, esta...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208785061364

    authors: Anderson EJ

    更新日期:2008-01-01 00:00:00

  • Exercise as an anabolic stimulus for bone.

    abstract::Mechanical loading provides an anabolic stimulus for bone. More importantly, the mechanosensing apparatus in bone directs osteogenesis to where it is most needed for improving bone strength. The biological processes involved in bone mechanotransduction are poorly understood and further investigation of the molecular m...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612043383755

    authors: Turner CH,Robling AG

    更新日期:2004-01-01 00:00:00

  • Clinical development of microbicides for the prevention of HIV infection.

    abstract::The HIV/AIDS pandemic continues its spread at a rate of over 15,000 new infections every day. Sexual transmission of HIV-1 is the dominant mode of this pandemic spread. For the first time since the disease emerged in the early 1980s, about half the 42 million people now living with HIV/AIDS worldwide are women. Worldw...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612043386374

    authors: D'Cruz OJ,Uckun FM

    更新日期:2004-01-01 00:00:00

  • Abnormal bodily experiences may be a marker of early schizophrenia?

    abstract::The purpose of this study is to answer the following question: What are the typical features of abnormal bodily experiences (ABEs) in persons affected by acute first-episode schizophrenia? Our overall objective is to contribute to enhance early diagnosis of schizophrenia, and providing supplementary diagnostic criteri...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/138161212799316181

    authors: Stanghellini G,Ballerini M,Fusar Poli P,Cutting J

    更新日期:2012-01-01 00:00:00

  • An Update of Patents, Preclinical and Clinical Outcomes of Lipid Nanoparticulate Systems.

    abstract:BACKGROUND:Lipid nanoparticles have attracted increased degree of scientific and commercial attention in the last decade. The lipidic nanoparticles have emerged as a potential alternative to other nano-scale systems due to their various advantages over them and also due to overcoming the shortcomings of the already ava...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612823666171122104216

    authors: Pathak K,Shankar R,Joshi M

    更新日期:2017-11-21 00:00:00

  • Benefits and Limitations of Polymorphic and Amorphous Forms of Active Pharmaceutical Ingredients.

    abstract::Active pharmaceutical ingredients (APIs) can exist in different polymorphic forms as well as in amorphous state. Polymorphic and amorphous forms of APIs can differ in physicochemical properties which in turn can significantly influence their therapeutic safety and effectiveness of the treatment. This review focuses on...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160804100036

    authors: Talaczynska A,Dzitko J,Cielecka-Piontek J

    更新日期:2016-01-01 00:00:00

  • Bioactive peptides: are there more antihypertensive mechanisms beyond ACE inhibition?

    abstract::Diet has a high relevance in health. Hypertension is a major risk factor for cardiovascular diseases and has an important impact on public health, and consequently on countries economy. Scientific research gathered strong evidence about the role of several dietary factors either in etiology or in treatment/prevention ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212802651670

    authors: Marques C,Amorim MM,Pereira JO,Pintado ME,Moura D,Calhau C,Pinheiro H

    更新日期:2012-01-01 00:00:00

  • Functional domains of aquaporin-1: keys to physiology, and targets for drug discovery.

    abstract::Aquaporins (AQPs) are expressed in physiologically essential tissues and organs in which edema and fluid imbalances are of major concern. Potential roles in brain water homeostasis and edema, angiogenesis, cell migration, development, neuropathological diseases, and cancer suggest that this family of membrane proteins...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161207782341349

    authors: Yool AJ

    更新日期:2007-01-01 00:00:00

  • Serum uric acid and diabetes: from pathophysiology to cardiovascular disease.

    abstract::Hyperuricemia, has been traditionally related to nephrolithiasis and gout. However, it has also been associated with the development of type 2 diabetes mellitus (T2DM) and cardiometabolic and cardiovascular diseases. Pathophysiologically, elevated serum uric acid (SUA) levels may be associated with abnormal lipid and ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612827666210104124320

    authors: Katsiki N,Dimitriadis GD,Mikhailidis DP

    更新日期:2021-01-04 00:00:00

  • Hyperpolarized Metabolic MR in the Study of Cardiac Function and Disease.

    abstract::Several diseases of the heart have been linked to an insufficient ability to generate enough energy (ATP) to sustain proper heart function. Hyperpolarized magnetic resonance (MR) is a novel technique that can visualize and quantify myocardial energy metabolism. Hyperpolarization enhances the MR signal from a biologica...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612820666140417113720

    authors: Lauritzen MH,Sogaard LV,Madsen PL,Ardenkjaer-Larsen JH

    更新日期:2014-01-01 00:00:00

  • Circulating endothelial progenitor cells characterization, function and relationship with cardiovascular risk factors.

    abstract::Since the first description of putative progenitor endothelial cells mobilized from bone marrow by stimuli like ischemia and cytokines, several studies in animals have confirmed their role in neovascularization of ischemic organs. In ischemic myocardium endothelial progenitor cells can prevent cardiomyocyte apoptosis,...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161207780831329

    authors: Balbarini A,Barsotti MC,Di Stefano R,Leone A,Santoni T

    更新日期:2007-01-01 00:00:00

  • Towards histone deacetylase inhibitors as new antimalarial drugs.

    abstract::Histone deacetylases (HDACs) are important enzymes that effect post-translational modifications of proteins by altering the acetylation state of lysine residues. HDACs control epigenetic changes that trigger cell transformation and proliferation of transformed cells associated with many diseases. These enzymes are val...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:

    authors: Andrews KT,Tran TN,Fairlie DP

    更新日期:2012-01-01 00:00:00

  • Applications of Magnetic Liposomes in Cancer Therapies.

    abstract::MNPs find numerous important biomedical applications owing to their high biocompatibility and unique magnetic properties at the bottom level. Among several other biomedical applications, MNPs are gaining importance in treating various kinds of cancer either as a hyperthermia agent alone or as a drug/gene carrier for s...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1389203720666190521114936

    authors: T S A,Shalumon KT,Chen JP

    更新日期:2019-01-01 00:00:00

  • Gamma-secretase as a pharmacological target in Alzheimer disease research: when, why and how?

    abstract::Alzheimer disease (AD) is characterized by excessive deposition of amyloid beta-peptides (Abeta peptides) in the form of senile plaques as well as neurofibrillary tangles (NFTs) in the brain. In the amyloidogenic pathway, the amyloid-beta precursor protein (APP) is cleaved by beta-secretase first, followed by gamma-se...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206778792994

    authors: Ziani-Cherif C,Mostefa-Kara B,Brixi-Gormat FZ

    更新日期:2006-01-01 00:00:00

  • Glucose metabolism and insulin resistance in sepsis.

    abstract::Hyperglycemia is a common feature of the critically ill in general and of patients with sepsis in particular. Even a moderate degree of hyperglycemia appears detrimental for the outcome of critically ill patients, since maintenance of normoglycemia (blood glucose levels

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208784980563

    authors: Van Cromphaut SJ,Vanhorebeek I,Van den Berghe G

    更新日期:2008-01-01 00:00:00

  • The mechanism of carvedilol in experimental viral myocarditis.

    abstract::Carvedilol is a nonselective β-blocker with α1-adrenergic blocking and antioxidant properties. A number of preclinical experiments and clinical trials have demonstrated that carvedilol provides prominent benefit in heart failure. However, less research has been done in the area of animal models of viral myocarditis. T...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212799958530

    authors: Yue-Chun L,Li-Sha G,Xue-Qiang G,Jia-Feng L

    更新日期:2012-01-01 00:00:00

  • Novel targets for antiinflammatory and antiarthritic agents.

    abstract::Inflammation is a complex pathological condition associated with exaggerated human immune system involving various activated immune cells and bio-molecules. Treatment of inflammatory diseases particularly chronic inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease etc. has been a big challen...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206777698945

    authors: Kulkarni RG,Achaiah G,Sastry GN

    更新日期:2006-01-01 00:00:00

  • The role of cyclooxygenase inhibitors in cancer prevention.

    abstract::Carcinogenesis results from the long-term accumulation of genetic and epigenetic aberrations at the molecular level, which are under constant selection pressure for growth advantage. Recognizing that cancer is the result of this long-term, multi-step process provides opportunities for molecularly targeted cancer preve...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612023394935

    authors: Anderson WF,Umar A,Viner JL,Hawk ET

    更新日期:2002-01-01 00:00:00

  • Nanoparticles in Ocular Drug Delivery Systems for Topical Administration: Promises and Challenges.

    abstract::The majority of pharmaceutical formulations for the treatment of ocular pathologies are for topical administration. However, this kind of ophthalmic formulations has disadvantages such as low bioavailability and, consequently, a reduced therapeutic effect. This happens due to the anatomical and physiological specifici...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150923095155

    authors: Almeida H,Amaral MH,Lobao P,Frigerio C,Sousa Lobo JM

    更新日期:2015-01-01 00:00:00

  • Proprotein Convertase Subtilisin/kexin type 9 Inhibition in Cardiovascular Prevention.

    abstract::Elevated levels of Low Density Lipoprotein cholesterol (LDL-C) are directly associated with increased risk for atherosclerotic cardiovascular and cerebrovascular events. Statins have been used to control serum LDLC and this has translated into reduction in cardiovascular and cerebrovascular events. However, despite hi...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612824666180111105201

    authors: Ali A,Costanzo P,Hoye A

    更新日期:2018-01-01 00:00:00

  • PCSK9 inhibitors for the management of dyslipidemia in people with Type 2 Diabetes: How low is too low?

    abstract::Diabetic patients are considered as high risk for development of atherosclerotic disease. Cholesterol treatment is of paramount importance in order to optimise cardiovascular outcomes in this subset of patients. Although statins are regarded as the mainstay of treatment, these may not be tolerated or as efficacious as...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200617170252

    authors: Felekos I,Karamasis GV,Pavlidis AN

    更新日期:2020-06-17 00:00:00

  • Historical Spice as a Future Drug: Therapeutic Potential of Piperlongumine.

    abstract:BACKGROUND:Spice and spice-derived compounds have been identified and explored for their health benefits since centuries. One of the spice long pepper has been traditionally used to treat chronic bronchitis, asthma, constipation, gonorrhea, paralysis of the tongue, diarrhea, cholera, malaria, viral hepatitis, respirato...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160601103027

    authors: Prasad S,Tyagi AK

    更新日期:2016-01-01 00:00:00

  • Review of QSAR models for enzyme classes of drug targets: Theoretical background and applications in parasites, hosts, and other organisms.

    abstract::The number of protein 3D structures without function annotation in Protein Data Bank (PDB) has been steadily increased. Many of these proteins are relevant for Pharmaceutical Design because they may be enzymes of different classes that could become drug targets. This fact has led in turn to an increment of demand for ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161210792389207

    authors: Concu R,Podda G,Ubeira FM,González-Díaz H

    更新日期:2010-01-01 00:00:00

  • Energetic Metabolic Roles in Pulmonary Arterial Hypertension and Right Ventricular Remodeling.

    abstract::The survival of patients with pulmonary arterial hypertension is closely related with right ventricular function. During the progression of right ventricular remodeling, energetic metabolism shifts from oxidative mitochondrial metabolism to glycolysis. In normal physiological conditions, cardiomyocytes use major sourc...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160614082712

    authors: Zhang R,Jing ZC

    更新日期:2016-01-01 00:00:00